Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Int J Lab Hematol. 2019 Jun;41(3):404-411. doi: 10.1111/ijlh.13000. Epub 2019 Mar 12.
Haemolysis, lipaemia and hyperbilirubinaemia represent important challenges in the coagulation laboratory. Test results are influenced not only by the degree of the interfering substance but also by the detection system.
We investigated the interference of free haemoglobin, triglycerides and bilirubin on a "modified activated protein C (APC) resistance test," protein C activity and protein S (antigen and activity) with two coagulation analysers, the STA-R Evolution and the ACL TOP.
Haemolysis interfered with all assays on the STA-R Evolution resulting in higher levels of protein C activity and lower levels of protein S and a decreased APC ratio compared with baseline levels. On the ACL TOP, haemolysis only diminished protein S antigen levels and the APC ratio. Lipaemia increased protein C activity and protein S activity levels on the STA-R Evolution, whereas APC-R decreased on the ACL TOP and protein S antigen could not be measured in any lipaemic samples. Hyperbilirubinaemia caused an increase in protein C activity and in protein S antigen and a decrease in APC-R on the STA-R Evolution, whereas a decline of protein C activity, of protein S antigen and of the APC-R could be observed in icteric samples on the ACL TOP.
Our data show that the degree of interference associated with haemolysis, lipaemia and hyperbilirubinaemia is different in several assays. Some assay limitations were not reproduced, and limitations stated in kit inserts cannot be assumed to apply to all analysers.
溶血、脂血和高胆红素血症是凝血实验室的重要挑战。检测结果不仅受干扰物质程度的影响,还受检测系统的影响。
我们研究了游离血红蛋白、甘油三酯和胆红素对两种凝血分析仪(STA-R Evolution 和 ACL TOP)上“改良活化蛋白 C (APC) 抵抗试验”、蛋白 C 活性和蛋白 S(抗原和活性)的干扰。
溶血对 STA-R Evolution 上的所有检测都有干扰,导致蛋白 C 活性升高,蛋白 S 降低,APC 比值与基线水平相比降低。在 ACL TOP 上,溶血仅降低蛋白 S 抗原水平和 APC 比值。脂血增加 STA-R Evolution 上的蛋白 C 活性和蛋白 S 活性,而 ACL TOP 上的 APC-R 降低,并且在任何脂血样本中都无法测量蛋白 S 抗原。高胆红素血症导致 STA-R Evolution 上的蛋白 C 活性和蛋白 S 抗原增加,APC-R 降低,而在 ACL TOP 上的黄疸样本中,可观察到蛋白 C 活性、蛋白 S 抗原和 APC-R 的下降。
我们的数据表明,溶血、脂血和高胆红素血症相关的干扰程度在几种检测中不同。有些检测的局限性无法重现,试剂盒说明书中的局限性不能假定适用于所有分析仪。